Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Merck shares drop 10% as pharma giant scraps trial of promising cancer drug
05:17am, Tuesday, 25'th Jun 2024
Merck & Co's Frankfurt-listed shares fell 10% on Tuesday morning after the pharmaceutical giant said it had decided to call off a Phase III trial of its cancer drug Xevinapant, in an unexpected turn t
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
05:04am, Tuesday, 25'th Jun 2024
Artificial intelligence (AI) has the potential to add nearly $16 trillion to the global economy by the turn of the decade. Eight top-tier billionaires sent shares of Nvidia to the chopping block in th
Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know
06:55pm, Monday, 24'th Jun 2024
Merck (MRK) closed the most recent trading day at $132.96, moving +1.71% from the previous trading session.
Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer
04:35pm, Monday, 24'th Jun 2024
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemoradi
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
04:30pm, Monday, 24'th Jun 2024
There are multiple reasons to consider exposure to pharmaceutical stocks for the long-term portfolio. First, pharma stocks have a low-beta and provide and help in reducing the overall beta of a portfo
With Robust AI Prospects Is IBM A Better Pick Over Merck Stock Within The Dow Index?
09:00am, Monday, 24'th Jun 2024
We believe that the computing behemoth IBM (NYSE: IBM) is currently a better pick over the pharmaceuticals giant Merck (NYSE: MRK). The decision to invest often comes down to finding the best stocks w
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
04:51am, Monday, 24'th Jun 2024
Biotech stocks are high-risk, high-return opportunities that are under the mercy of several make-or-break catalysts, most of which are binary events. It pays to remain cognizant of the timing of these
Merck (MRK) Beats Stock Market Upswing: What Investors Need to Know
06:55pm, Tuesday, 18'th Jun 2024
Merck (MRK) closed at $127.99 in the latest trading session, marking a +0.38% move from the prior day.
Merck Prepares to Take on Pfizer After Pneumococcal Vaccine Approval
01:25pm, Tuesday, 18'th Jun 2024
Pfizer currently dominates the market for pneumococcal vaccines. Merck aims to change that.
FDA approves Merck's pneumonia vaccine for adults
12:45pm, Tuesday, 18'th Jun 2024
The Food and Drug Administration (FDA) has approved Merck's (MRK) new vaccine to protect adults from pneumonia. Yahoo Finance's Anjalee Khemlani reports more on how the vaccine works as the pharmaceut
Merck Stock Edges Higher on FDA Vaccine Approval
10:04am, Tuesday, 18'th Jun 2024
The U.S. Food and Drug Administration (FDA) approved Merck & Co Inc's (NYSE:MRK) next-generation vaccine to protect adults against the pneumococcal disease.
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
09:55am, Tuesday, 18'th Jun 2024
Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV specifically designed for adults to be approved by the FDA.
US FDA approves Merck's pneumococcal vaccine for adults
05:52pm, Monday, 17'th Jun 2024
Merck said on Monday the U.S. Food and Drug Administration has approved its next-generation vaccine to protect adults against pneumococcal disease.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--FDA Approves CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease & Pneumococcal Pneumonia in Adults.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--FDA Approves Merck's KEYTRUDA Plus Chemotherapy as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma.
